2020
DOI: 10.1111/jdv.16519
|View full text |Cite
|
Sign up to set email alerts
|

Comment on ‘Cutaneous manifestations in COVID‐19: a first perspective’ by Recalcati S

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
163
0
20

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(185 citation statements)
references
References 4 publications
2
163
0
20
Order By: Relevance
“…Furthermore, no evidence exists that the degree of cutaneous involvement is related to the severity of the disease 3 . Previous studies report cutaneous involvement in a range from 0.2% 4 to 20% 5 . Based on the growing reports in the literature, we can argue that cutaneous symptoms of the new coronavirus are similar to those of other common viral infections 3 .…”
Section: Figurementioning
confidence: 97%
“…Furthermore, no evidence exists that the degree of cutaneous involvement is related to the severity of the disease 3 . Previous studies report cutaneous involvement in a range from 0.2% 4 to 20% 5 . Based on the growing reports in the literature, we can argue that cutaneous symptoms of the new coronavirus are similar to those of other common viral infections 3 .…”
Section: Figurementioning
confidence: 97%
“…Recalcati et al 8 identified maculopapular eruptions in 14 out of 18 patients with COVID‐19, while Hedou et al 9 reported similar eruptions in two patients. Mahe et al, 13 Hunt et al, 14 Estebanez et al, 15 Alramthan et al, 16 and Ahouache 17 reported single cases of maculopapular eruptions in patients with COVID‐19.…”
Section: Maculopapular Lesionsmentioning
confidence: 98%
“…Hedou et al observed urticarial eruption in two out of 103 patients with COVID‐19. In one of these patients, the eruption occurred in the prodromal stage of the infection 9 . Henry et al identified urticarial lesions limited to the face and acral regions in a 27‐year‐old COVID‐19 positive female patient who did not have a high fever 10 .…”
Section: Urticarial Lesionsmentioning
confidence: 99%
“…8,13,30 For studies that examined a larger cohort of COVID-19+ patients (both with cutaneous and extracutaneous symptoms), the prevalence of skin symptoms ranged from 4.9-20.4%. 3,12 3.2 Characteristics of cutaneous symptoms Table 2 summarizes the characteristics of the cutaneous symptoms described in the COVID-19 literature. These dermatologic manifestations were then grouped together into categories using common descriptive terminology and photographic evidence.…”
Section: Study Characteristics and Patient Demographicsmentioning
confidence: 99%
“…Cutaneous manifestations resembling SDRIFE, PRE and FE were the least common (0.3% combined). 4,12,23,3,10 ** Studies by De Masson, Fernandez-Nieto, Piccolo, Recalcati and Torres-Navarro excluded because of inability to extract exact data. 3,16,33,35,36 ** Other rashes included: eruptive cherry angioma (n = 1), reactivation of HSV-1 (n = 1), and unspecified cases of eczematous, angiomatous or annular lesions (n = 41).…”
Section: Study Characteristics and Patient Demographicsmentioning
confidence: 99%